DOCSLIB.ORG

Convergent and Divergent Cellular Responses by Erbb4 Isoforms in Mammary Epithelial Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Convergent and Divergent Cellular Responses by Erbb4 Isoforms in Mammary Epithelial Cells Published OnlineFirst May 14, 2014; DOI: 10.1158/1541-7786.MCR-13-0637 Molecular Cancer Genomics Research Convergent and Divergent Cellular Responses by ErbB4 Isoforms in Mammary Epithelial Cells Vikram B. Wali, Jonathan W. Haskins, Maureen Gilmore-Hebert, James T. Platt, Zongzhi Liu, and David F. Stern Abstract Associations of ErbB4 (ERBB4/HER4), the fourth member of the EGFR family, with cancer are variable, possibly as a result of structural diversity of this receptor. There are multiple structural isoforms of ERBB4 arising by alternative mRNA splicing, and a subset undergo proteolysis that releases membrane-anchored and soluble isoforms that associate with transcription factors and coregulators to modulate transcription. To compare the differential and common signaling activities of full-length (FL) and soluble intracellular isoforms of ERBB4, four JM-a isoforms (FL and soluble intracellular domain (ICD) CYT-1 and CYT-2) were expressed in isogenic MCF10A cells and their biologic activities were analyzed. Both FL and ICD CYT-2 promoted cell proliferation and invasion, and CYT-1 suppressed cell growth. Transcriptional profiling revealed several new and underexplored ERBB4-regulated transcripts, including: proteases/protease inhibitors (MMP3 and SERPINE2), the YAP/Hippo pathway (CTGF, CYR61, and SPARC), the mevalonate/cholesterol pathway (HMGCR, HMGCS1, LDLR, and DHCR7), and cytokines (IL8, CCL20, and CXCL1). Many of these transcripts were subsequently validated in a luminal breast cancer cell line that normally expresses ERBB4. Furthermore, ChIP-seq experiments identified ADAP1, APOE, SPARC, STMN1, and MXD1 as novel molecular targets of ERBB4. These findings clarify the diverse biologic activities of ERBB4 isoforms, and reveal new and divergent functions. Implications: ErbB4 as a regulator of Hippo and mevalonate pathways provides new insight into milk production and anabolic processes in normal mammary epithelia and cancer. Mol Cancer Res; 12(8); 1140–55. Ó2014 AACR. Introduction Inconsistent associations of ERBB4 with cancer may be The four receptor kinases in the epidermal growth factor explained by the diversity of ERBB4-regulated signaling (EGF) family, EGFR, ERBB2, ERBB3, and ERBB4 regu- processes enabled by mRNA splice variants. JM-a and late developmental processes in the nervous system, cardio- JM-b isoforms differ in the extracellular juxtamembrane vascular system, and in epithelia. EGFR, ERBB2, and domain (8). JM-b isoforms are conventional receptor tyro- ERBB3 are common drivers in human carcinoma and sine kinases (RTK): The ligands, including neuregulin 1 glioblastoma and are targets for cancer therapeutics approved (NRG1), induce receptor phosphorylation and activate by the US FDA. But, ERBB4 has a more ambiguous subsequent signal transduction. In contrast, JM-a isoforms influence on cancer. ERBB4 is overexpressed in medullo- have a metalloproteinase cleavage site that is clipped by blastoma, and candidate ERBB4–activating mutations have tumor necrosis factor-a-converting enzyme (TACE) in been identified in lung cancer, melanoma, and other cancers response to NRG1 binding. This releases the extracellular (1–4). Nonetheless, conflicting reports have been published domain, leaving the membrane-anchored m80 form. on ERBB4 as a prognostic marker, with both positive and ERBB4 m80 can then undergo intramembrane cleavage by negative clinical outcome correlations (5–7). g-secretase to release the soluble s80 form comprising the intracellular domain (ICD). s80 relocalizes to mitochondria and the nucleus (9, 10), in which it binds transcriptional Authors' Affiliation: Department of Pathology, Yale School of Medicine, coregulators and transcription factors. New Haven, Connecticut A second alternatively spliced region in the ICD includes Note: Supplementary data for this article are available at Molecular Cancer (CYT-1) or excludes (CYT-2) an exon that encodes a binding Research Online (http://mcr.aacrjournals.org/). site for the p85 adaptor subunit of phosphatidyl inositol (30) V.B. Wali and J.W. Haskins contributed equally to this work. kinase, and an overlapping WW domain PPXY-binding site. Corresponding Author: Vikram B. Wali, Yale University School of Med- Divergence of signaling processes incited by the four ERBB4 icine, 300 George Street, New Haven, CT 06511. Phone: 203-737-6491; isoforms may explain the discordance in the ERBB4 cancer Fax: 203-785-7232; E-mail: [email protected] literature: Most studies fail to consider these isoforms sepa- doi: 10.1158/1541-7786.MCR-13-0637 rately, and the isoform(s) expressed and subcellular localiza- Ó2014 American Association for Cancer Research. tion of ERBB4 have an impact on prognosis (11, 12). 1140 Mol Cancer Res; 12(8) August 2014 Downloaded from mcr.aacrjournals.org on September 27, 2021. © 2014 American Association for Cancer Research. Published OnlineFirst May 14, 2014; DOI: 10.1158/1541-7786.MCR-13-0637 Biologic Effects of ERBB4 Isoforms in Mammary Epithelial Cells We previously identified binding of both ERBB4 ICD aged as lentivirus by cotransfecting 293T cells with pLP/ isoforms (CYT-1 and CYT-2) with the transcriptional VSV-G, pLP1(Gag/Pol), pLP2(rev), and pcTat (tat) using corepressor KAP1, and identified 16 other candidate inter- Lipofectamine 2000 (Invitrogen Corporation). MCF10A actors, including ubiquitin ligases ITCH and WWP2 (13). cells were infected with a multiplicity of infection of approx- The ERBB4 ICD has been reported by others to associate imately 5 in the presence of 8 mg/mL polybrene. Expression with transcription factors ERa and Stat5, with transcrip- of ERBB4 in these MCF10A cells was tested 24 and 72 hours tional coregulators, including YAP, WWOX, ETO2, and a after infection. Polyclonal stable cell lines were selected with TAB2/N-CoR complex, and with ubiquitin ligases Itch and puromycin. The above FL CYT-1 and CYT-2 ERBB4 Mdm2 (14–20). To better understand the diverse biologic constructs were also packaged into pInducer20 DOX-induc- outcomes associated with activity of the full-length (FL) and ible expression plasmids that were used to infect ERBB4 KD truncated ERBB4 isoforms, we have explored the pheno- T47D stables to reexpress specific JM-a ERBB4 CYT-1 or typic, transcriptional and signaling consequences of intro- CYT-2 isoform. The pInducer20 DOX-inducible expres- duction and activation of ERBB4 isoforms, and identified sion plasmid used for cloning was generously provided by candidate gene target interactions by chromatin immuno- Dr. Stephen Elledge, Department of Genetics, Harvard precipitation-sequencing (ChIP-seq). Medical School (21). ICD expression cDNAs encoding CYT-1 (amino acids 676–1308) and CYT-2 (amino acids 676–1294) isoforms Materials and Methods (GeneCopoeia) were cloned into the lentiviral TA cloning Cell culture vector Lenti6.3-V5 in frame with the 30 V5 epitope tag (Life MCF10A cells were maintained in DMEM/F12 supple- Sciences Technologies). Stable cell lines for the ICDs and the mented with 5% horse serum, 20 ng/mL EGF, 0.5 mg/mL vector control (vector) were selected with blasticidin. hydrocortisone, 100 ng/mL cholera toxin, 10 mg/mL insu- lin, 100 U/mL penicillin, and 100 mg/mL streptomycin. Immunoblotting MCF10A cells stably expressing FL JM-a CYT-1–ERBB4 For NRG1 stimulation, cells were plated at 1 Â 106 cells isoform (CYT-1 MCF10A) or JM-a CYT-2–ERBB4 iso- per 100-mm plate. The following day, cells were incubated form (CYT-2 MCF10A) or vector only (V-MCF10A) were in serum-free OptiMEM medium for 48 hours, followed by generated by lentiviral infection and selection with 10 incubation with 100 ng/mL NRG1. Sample buffer lysates mg/mL puromycin and maintained in 1 mg/mL puromycin. normalized for protein concentration were analyzed by MCF10A cells stably expressing either of the ICD ERBB4 electrophoresis in 4% to 12% NuPAGE SDS–polyacryl- isoforms: CYT-1 or CYT-2 were produced by lentiviral amide midigels (Life Technologies Corporation). For immu- infection, selection in with 10 mg/mL blastocidin and noblotting, polyvinylidene difluoride membranes were maintenance in 7 mg/mL blastocidin. T47D and MDA- blocked with 2% BSA in 10 mmol/L Tris-HCl, 50 MB-231 cells were cultured in RPMI-1640 with glutamate mmol/L NaCl, 0.1% Tween 20, pH 7.4 (TBST), and (Gibco) containing 100 U/mL penicillin, 100 mg/mL strep- incubated with anti–phospho-ERBB4 (Tyr 1056; ref. 22), tomycin, and 10% fetal bovine serum (BioWest). FuGENE phospho-ERBB4 Tyr 1284 (Cell Signaling Technology; 6 (Roche) or Lipofectamine 2000 reagent (Invitrogen Cor- #4757), ERBB4 (sc-283), GAPDH (Santa Cruz Biotech- poration) were used for transfections. T47D cells were nology), phospho-MAPK (Thr202/Tyr204), or phospho- 0 transduced with pLKO ERBB4 3 untranslated region AKT (Ser473;Cell Signaling Technology) diluted 1:5,000 to (UTR)–directed shRNA (Sigma; TRCN0000314628) or 1:20,000 in TBST/2% BSA for 2 hours. Membranes were scrambled control and selected in 1 mg/mL puromycin. washed five times with TBST, incubated with horseradish These ERBB4 knockdown (KD) T47D stable cell lines peroxide–conjugated secondary antibodies in TBST/2% were subsequently infected with pInducer20 ERBB4 BSA for 1 hour, rinsed with TBST, and detected by chemi- JM-a CYT-1, CYT-2, or vector control and selected in luminescence (SuperSignal West Pico Chemiluminescent 400 mg/mL G418. T47D ERBB4 KD, pInducer20 CYT- Substrate; Pierce). 1 or CYT-2 stable cell lines were maintained in 1 mg/mL puromycin, 200 mg/mL G418, and ERBB4 KD and doxy- Cell proliferation assays cycline (DOX)-inducible ERBB4 isoform reexpression was In Fig. 2A–C, cells were plated at 1,000 cells per well in confirmed by Western blot analysis. 96-well plates. The next day, four wells per group were fed either serum-free OptiMEM medium or 5% horse serum Plasmids containing medium, Æ 100 ng/mL NRG1, and incubated Lentiviral expression plasmids for JM-a FL CYT-1 for 5 days with refeeding day 2. Proliferation was assayed ERBB4 (EX-A0212-Lv105), CYT-2 ERBB4 (EX-Z4265- daily using the ATP-based CellTiter-Glo Luminescent Cell Lv105), and negative control vector (EX-EGFP-Lv105), Viability Assay (Promega).
Load more

Recommended publications
  • Mutation Analysis in Myeloproliferative Neoplasms AHS - M2101
    Corporate Medical Policy Mutation Analysis in Myeloproliferative Neoplasms AHS - M2101 File Name: mutation_analysis_in_myeloproliferative_neoplasms Origination: 1/1/2019 Last CAP review: 8/2021 Next CAP review: 8/2022 Last Review: 8/2021 Description of Procedure or Service Myeloproliferative neoplasms (MPN) are a heterogeneous group of clonal disorders characterized by overproduction of one or more differentiated myeloid lineages (Grinfeld, Nangalia, & Green, 2017). These include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). The majority of MPN result from somatic mutations in the 3 driver genes, JAK2, CALR, and MPL, which represent major diagnostic criteria in combination with hematologic and morphological abnormalities (Rumi & Cazzola, 2017). Related Policies: BCR-ABL 1 Testing for Chronic Myeloid Leukemia AHS-M2027 ***Note: This Medical Policy is complex and technical. For questions concerning the technical language and/or specific clinical indications for its use, please consult your physician. Policy BCBSNC will provide coverage for mutation analysis in myeloproliferative neoplasms when it is determined to be medically necessary because the medical criteria and guidelines shown below are met. Benefits Application This medical policy relates only to the services or supplies described herein. Please refer to the Member's Benefit Booklet for availability of benefits. Member's benefits may vary according to benefit design; therefore member benefit language should be reviewed before applying the terms of this medical policy. When Mutation Analysis in Myeloproliferative Neoplasms is covered 1. JAK2, CALR or MPL mutation testing is considered medically necessary for the diagnosis of patients presenting with clinical, laboratory, or pathological findings suggesting classic forms of myeloproliferative neoplasms (MPN), that is, polycythemia vera (PV), essential thrombocythemia (ET), or primary myelofibrosis (PMF) when ordered by a hematology and/or oncology specialist in the following situations: A.
    [Show full text]
  • Supp Material.Pdf
    Legends for Supplemental Figures and Tables Figure S1. Expression of Tlx during retinogenesis. (A) Staged embryos were stained for β- galactosidase knocked into the Tlx locus to indicate Tlx expression. Tlx was expressed in the neural blast layer in the early phase of neural retina development (blue signal). (B) Expression of Tlx in neural retina was quantified using Q-PCR at multiple developmental stages. Figure S2. Expression of p27kip1 and cyclin D1 (Ccnd1) at various developmental stages in wild-type or Tlx-/- retinas. (A) Q-PCR analysis of p27kip1 mRNA expression. (B) Western blotting analysis of p27kip1 protein expression. (C) Q-PCR analysis of cyclin D1 mRNA expression. Figure S3. Q-PCR analysis of mRNA expression of Sf1 (A), Lrh1 (B), and Atn1 (C) in wild-type mouse retinas. RNAs from testis and liver were used as controls. Table S1. List of genes dysregulated both at E15.5 and P0 Tlx-/- retinas. Gene E15.5 P0 Cluste Gene Title Fold Fold r Name p-value p-value Change Change nuclear receptor subfamily 0, group B, Nr0b1 1.65 0.0024 2.99 0.0035 member 1 1 Pou4f3 1.91 0.0162 2.39 0.0031 POU domain, class 4, transcription factor 3 1 Tcfap2d 2.18 0.0000 2.37 0.0001 transcription factor AP-2, delta 1 Zic5 1.66 0.0002 2.02 0.0218 zinc finger protein of the cerebellum 5 1 Zfpm1 1.85 0.0030 1.88 0.0025 zinc finger protein, multitype 1 1 Pten 1.60 0.0155 1.82 0.0131 phospatase and tensin homolog 2 Itgb5 -1.85 0.0063 -1.85 0.0007 integrin beta 5 2 Gpr49 6.86 0.0001 15.16 0.0001 G protein-coupled receptor 49 3 Cmkor1 2.60 0.0007 2.72 0.0013
    [Show full text]
  • Core Transcriptional Regulatory Circuitries in Cancer
    Oncogene (2020) 39:6633–6646 https://doi.org/10.1038/s41388-020-01459-w REVIEW ARTICLE Core transcriptional regulatory circuitries in cancer 1 1,2,3 1 2 1,4,5 Ye Chen ● Liang Xu ● Ruby Yu-Tong Lin ● Markus Müschen ● H. Phillip Koeffler Received: 14 June 2020 / Revised: 30 August 2020 / Accepted: 4 September 2020 / Published online: 17 September 2020 © The Author(s) 2020. This article is published with open access Abstract Transcription factors (TFs) coordinate the on-and-off states of gene expression typically in a combinatorial fashion. Studies from embryonic stem cells and other cell types have revealed that a clique of self-regulated core TFs control cell identity and cell state. These core TFs form interconnected feed-forward transcriptional loops to establish and reinforce the cell-type- specific gene-expression program; the ensemble of core TFs and their regulatory loops constitutes core transcriptional regulatory circuitry (CRC). Here, we summarize recent progress in computational reconstitution and biologic exploration of CRCs across various human malignancies, and consolidate the strategy and methodology for CRC discovery. We also discuss the genetic basis and therapeutic vulnerability of CRC, and highlight new frontiers and future efforts for the study of CRC in cancer. Knowledge of CRC in cancer is fundamental to understanding cancer-specific transcriptional addiction, and should provide important insight to both pathobiology and therapeutics. 1234567890();,: 1234567890();,: Introduction genes. Till now, one critical goal in biology remains to understand the composition and hierarchy of transcriptional Transcriptional regulation is one of the fundamental mole- regulatory network in each specified cell type/lineage.
    [Show full text]
  • Tbx2 Is Essential for Patterning the Atrioventricular Canal and for Morphogenesis of the Outflow Tract During Heart Development Zachary Harrelson1, Robert G
    Research article 5041 Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development Zachary Harrelson1, Robert G. Kelly1, Sarah N. Goldin1, Jeremy J. Gibson-Brown1,2,3, Roni J. Bollag3,4, Lee M. Silver3 and Virginia E. Papaioannou1,* 1Department of Genetics and Development, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA 2Department of Biology, Washington University, St Louis, MO 63130, USA 3Department of Molecular Biology, Lewis Thomas Laboratory, Princeton University, Princeton, NJ 08544, USA 4Institute of Molecular Genetics and Development, Medical College of Georgia, Augusta, GA 30912, USA *Author for correspondence (e-mail: [email protected]) Accepted 29 July 2004 Development 131, 5041-5052 Published by The Company of Biologists 2004 doi:10.1242/dev.01378 Summary Tbx2 is a member of the T-box transcription factor gene that Tbx2 is required to repress chamber differentiation in family, and is expressed in a variety of tissues and organs the atrioventricular canal at 9.5 dpc. Analysis of during embryogenesis. In the developing heart, Tbx2 is homozygous mutants also highlights a role for Tbx2 during expressed in the outflow tract, inner curvature, hindlimb digit development. Despite evidence that TBX2 atrioventricular canal and inflow tract, corresponding to negatively regulates the cell cycle control genes Cdkn2a, a myocardial zone that is excluded from chamber Cdkn2b and Cdkn1a in cultured cells, there is no evidence differentiation at 9.5 days post coitus (dpc). We have used that loss of Tbx2 function during mouse development targeted mutagenesis in mice to investigate Tbx2 function.
    [Show full text]
  • 942.Full.Pdf
    Original Article Opposite Effect of JAK2 on Insulin-Dependent Activation of Mitogen-Activated Protein Kinases and Akt in Muscle Cells Possible Target to Ameliorate Insulin Resistance Ana C.P. Thirone, Lellean JeBailey, Philip J. Bilan, and Amira Klip Many cytokines increase their receptor affinity for Janus kinases (JAKs). Activated JAK binds to signal transducers and activators of transcription, insulin receptor substrates olypeptides such as erythropoietin, prolactin, (IRSs), and Shc. Intriguingly, insulin acting through its leptin, angiotensin, growth hormone, most inter- own receptor kinase also activates JAK2. However, the leukins, and interferon-␥ bind to receptors that impact of such activation on insulin action remains un- Plack intrinsic kinase activity, recruiting and acti- known. To determine the contribution of JAK2 to insulin vating cytoplasmic tyrosine kinases of the Janus family signaling, we transfected L6 myotubes with siRNA against (JAK) consisting of JAK1, JAK2, JAK3, and Tyk2 (1–3). JAK2 (siJAK2), reducing JAK2 protein expression by 75%. Activated JAK phosphorylates tyrosine residues within Insulin-dependent phosphorylation of IRS1/2 and Shc was not affected by siJAK2, but insulin-induced phosphoryla- itself and the associated receptor forming high-affinity tion of the mitogen-activated protein kinases (MAPKs) binding sites for a variety of signaling proteins containing Src homology 2 and other phosphotyrosine-binding do- extracellular signal–related kinase, p38, and Jun NH2- terminal kinase and their respective upstream kinases mains, including signal transducers and activators of tran- MKK1/2, MKK3/6, and MKK4/7 was significantly lowered scription, insulin receptor substrates (IRSs), and the when JAK2 was depleted, correlating with a significant adaptor protein Shc (1–4).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • To Study Mutant P53 Gain of Function, Various Tumor-Derived P53 Mutants
    Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science By Shama K Khokhar M.Sc., Bilaspur University, 2004 B.Sc., Bhopal University, 2002 2007 1 COPYRIGHT SHAMA K KHOKHAR 2007 2 WRIGHT STATE UNIVERSITY SCHOOL OF GRADUATE STUDIES Date of Defense: 12-03-07 I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY SUPERVISION BY SHAMA KHAN KHOKHAR ENTITLED Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression BE ACCEPTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science Madhavi P. Kadakia, Ph.D. Thesis Director Daniel Organisciak , Ph.D. Department Chair Committee on Final Examination Madhavi P. Kadakia, Ph.D. Steven J. Berberich, Ph.D. Michael Leffak, Ph.D. Joseph F. Thomas, Jr., Ph.D. Dean, School of Graduate Studies 3 Abstract Khokhar, Shama K. M.S., Department of Biochemistry and Molecular Biology, Wright State University, 2007 Differential effect of TAp63γ mutants on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. p63, a member of the p53 gene family, known to play a role in development, has more recently also been implicated in cancer progression. Mice lacking p63 exhibit severe developmental defects such as limb truncations, abnormal skin, and absence of hair follicles, teeth, and mammary glands. Germline missense mutations of p63 have been shown to be responsible for several human developmental syndromes including SHFM, EEC and ADULT syndromes and are associated with anomalies in the development of organs of epithelial origin.
    [Show full text]
  • Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic Opportunities
    cancers Review Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic Opportunities Jordi Alcaraz 1,2,3,*, Rafael Ikemori 1 , Alejandro Llorente 1 , Natalia Díaz-Valdivia 1 , Noemí Reguart 2,4 and Miguel Vizoso 5,* 1 Unit of Biophysics and Bioengineering, Department of Biomedicine, School of Medicine and Health Sciences, Universitat de Barcelona, 08036 Barcelona, Spain; [email protected] (R.I.); [email protected] (A.L.); [email protected] (N.D.-V.) 2 Thoracic Oncology Unit, Hospital Clinic Barcelona, 08036 Barcelona, Spain; [email protected] 3 Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), 08028 Barcelona, Spain 4 Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain 5 Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands * Correspondence: [email protected] (J.A.); [email protected] (M.V.) Simple Summary: Lung cancer is the leading cause of cancer death among both men and women, partly due to limited therapy responses. New avenues of knowledge are indicating that lung cancer cells do not form a tumor in isolation but rather obtain essential support from their surrounding host tissue rich in altered fibroblasts. Notably, there is growing evidence that tumor progression and even the current limited responses to therapies could be prevented by rescuing the normal behavior of fibroblasts, which are critical housekeepers of normal tissue function. For this purpose, it is key Citation: Alcaraz, J.; Ikemori, R.; to improve our understanding of the molecular mechanisms driving the pathologic alterations of Llorente, A.; Díaz-Valdivia, N.; fibroblasts in cancer.
    [Show full text]
  • T-Brain Regulates Archenteron Induction Signal 5207 Range of Amplification
    Development 129, 5205-5216 (2002) 5205 Printed in Great Britain © The Company of Biologists Limited 2002 DEV5034 T-brain homologue (HpTb) is involved in the archenteron induction signals of micromere descendant cells in the sea urchin embryo Takuya Fuchikami1, Keiko Mitsunaga-Nakatsubo1, Shonan Amemiya2, Toshiya Hosomi1, Takashi Watanabe1, Daisuke Kurokawa1,*, Miho Kataoka1, Yoshito Harada3, Nori Satoh3, Shinichiro Kusunoki4, Kazuko Takata1, Taishin Shimotori1, Takashi Yamamoto1, Naoaki Sakamoto1, Hiraku Shimada1 and Koji Akasaka1,† 1Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Higashi-Hiroshima 739-8526, Japan 2Department of Integrated Biosciences, Graduate School of Frontier Sciences, University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan 3Department of Zoology, Graduate School of Science, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan 4LSL, Nerima-ku, Tokyo 178-0061, Japan *Present address: Evolutionary Regeneration Biology Group, RIKEN Center for Developmental Biology, Kobe 650-0047, Japan †Author for correspondence (e-mail: [email protected]) Accepted 30 July 2002 SUMMARY Signals from micromere descendants play a crucial role in cells, the initial specification of primary mesenchyme cells, sea urchin development. In this study, we demonstrate that or the specification of endoderm. HpTb expression is these micromere descendants express HpTb, a T-brain controlled by nuclear localization of β-catenin, suggesting homolog of Hemicentrotus pulcherrimus. HpTb is expressed that
    [Show full text]
  • Accompanies CD8 T Cell Effector Function Global DNA Methylation
    Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function Christopher D. Scharer, Benjamin G. Barwick, Benjamin A. Youngblood, Rafi Ahmed and Jeremy M. Boss This information is current as of October 1, 2021. J Immunol 2013; 191:3419-3429; Prepublished online 16 August 2013; doi: 10.4049/jimmunol.1301395 http://www.jimmunol.org/content/191/6/3419 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2013/08/20/jimmunol.130139 Material 5.DC1 References This article cites 81 articles, 25 of which you can access for free at: http://www.jimmunol.org/content/191/6/3419.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 1, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function Christopher D. Scharer,* Benjamin G. Barwick,* Benjamin A. Youngblood,*,† Rafi Ahmed,*,† and Jeremy M.
    [Show full text]
  • The Forkhead-Box Family of Transcription Factors: Key Molecular Players in Colorectal Cancer Pathogenesis Paul Laissue
    Laissue Molecular Cancer (2019) 18:5 https://doi.org/10.1186/s12943-019-0938-x REVIEW Open Access The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis Paul Laissue Abstract Colorectal cancer (CRC) is the third most commonly occurring cancer worldwide and the fourth most frequent cause of death having an oncological origin. It has been found that transcription factors (TF) dysregulation, leading to the significant expression modifications of genes, is a widely distributed phenomenon regarding human malignant neoplasias. These changes are key determinants regarding tumour’s behaviour as they contribute to cell differentiation/proliferation, migration and metastasis, as well as resistance to chemotherapeutic agents. The forkhead box (FOX) transcription factor family consists of an evolutionarily conserved group of transcriptional regulators engaged in numerous functions during development and adult life. Their dysfunction has been associated with human diseases. Several FOX gene subgroup transcriptional disturbances, affecting numerous complex molecular cascades, have been linked to a wide range of cancer types highlighting their potential usefulness as molecular biomarkers. At least 14 FOX subgroups have been related to CRC pathogenesis, thereby underlining their role for diagnosis, prognosis and treatment purposes. This manuscript aims to provide, for the first time, a comprehensive review of FOX genes’ roles during CRC pathogenesis. The molecular and functional characteristics of most relevant FOX molecules (FOXO, FOXM1, FOXP3) have been described within the context of CRC biology, including their usefulness regarding diagnosis and prognosis. Potential CRC therapeutics (including genome-editing approaches) involving FOX regulation have also been included. Taken together, the information provided here should enable a better understanding of FOX genes’ function in CRC pathogenesis for basic science researchers and clinicians.
    [Show full text]
  • UNIVERSITY of CALIFORNIA RIVERSIDE Investigations Into The
    UNIVERSITY OF CALIFORNIA RIVERSIDE Investigations into the Role of TAF1-mediated Phosphorylation in Gene Regulation A Dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Cell, Molecular and Developmental Biology by Brian James Gadd December 2012 Dissertation Committee: Dr. Xuan Liu, Chairperson Dr. Frank Sauer Dr. Frances M. Sladek Copyright by Brian James Gadd 2012 The Dissertation of Brian James Gadd is approved Committee Chairperson University of California, Riverside Acknowledgments I am thankful to Dr. Liu for her patience and support over the last eight years. I am deeply indebted to my committee members, Dr. Frank Sauer and Dr. Frances Sladek for the insightful comments on my research and this dissertation. Thanks goes out to CMDB, especially Dr. Bachant, Dr. Springer and Kathy Redd for their support. Thanks to all the members of the Liu lab both past and present. A very special thanks to the members of the Sauer lab, including Silvia, Stephane, David, Matt, Stephen, Ninuo, Toby, Josh, Alice, Alex and Flora. You have made all the years here fly by and made them so enjoyable. From the Sladek lab I want to thank Eugene, John, Linh and Karthi. Special thanks go out to all the friends I’ve made over the years here. Chris, Amber, Stephane and David, thank you so much for feeding me, encouraging me and keeping me sane. Thanks to the brothers for all your encouragement and prayers. To any I haven’t mentioned by name, I promise I haven’t forgotten all you’ve done for me during my graduate years.
    [Show full text]